Retinal metastasis regression with eribulin in a heavily pretreated breast cancer patient
Author:
Affiliation:
1. Oncology Unit, Macerata Hospital, Area Vasta 3 Marche, Via S. Lucia, 1 - 62100, Macerata, Italy
2. Ophthalmology Unit, Macerata Hospital, Area Vasta 3 Marche, Via S. Lucia,1 - 62100, Macerata, Italy
Abstract
Publisher
Future Medicine Ltd
Subject
Cancer Research,Oncology,General Medicine
Link
https://www.futuremedicine.com/doi/pdf/10.2217/fon.15.148
Reference20 articles.
1. Retinal tumors in adults: diagnosis and management
2. Survival in patients with brain metastases from breast cancer
3. Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
4. Abstract S6-6: A Phase III, open-label, randomized, multicenter study of eribulin mesylate versus capecitabine in patients with locally advanced or metastatic breast cancer previously treated with anthracyclines and taxanes
5. Phase 2, Multicenter, Single-Arm Study of Eribulin Mesylate With Trastuzumab as First-Line Therapy for Locally Recurrent or Metastatic HER2-Positive Breast Cancer
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. SIMULTANEOUS CHOROIDAL AND RETINAL METASTASES FROM LUNG CARCINOMA;RETINAL Cases & Brief Reports;2020
2. Retinal Metastasis;Ocular Oncology;2019
3. Eribulin in ‘field practice’: an overview of the Italian experience;Future Oncology;2015-08
4. Eribulin in the Management of Advanced Breast Cancer: Implications of Current Research Findings;Breast Cancer: Basic and Clinical Research;2015-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3